RHY 0.00% 10.0¢ rhythm biosciences limited

Ann: Final Antibody Selection Complete, page-3

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 93 Posts.
    lightbulb Created with Sketch. 29
    A solid progress update, although it doesn’t contain many surprises. Certainly another de-risked step on the way to Colostat as a marketable product. There’s little trade volume and one has to wonder what it’s going to take to bring the share price back above the ipo of .20. Seems very undervalued considering the milestones that have been achieved. A good result from Study 6 (Q1 2029?) will undoubtably make this company worth a lot of money.
    Last edited by Kenny73: 05/10/18
 
watchlist Created with Sketch. Add RHY (ASX) to my watchlist
(20min delay)
Last
10.0¢
Change
0.000(0.00%)
Mkt cap ! $15.41M
Open High Low Value Volume
10.0¢ 10.0¢ 10.0¢ $5K 50K

Buyers (Bids)

No. Vol. Price($)
2 55913 10.0¢
 

Sellers (Offers)

Price($) Vol. No.
10.5¢ 18707 1
View Market Depth
Last trade - 10.08am 05/11/2024 (20 minute delay) ?
RHY (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.